Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00438204
What this trial is testing

Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 39
Large-scale testing (Phase 3)Study completedNCT02657434
What this trial is testing

Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 578
Post-approval studies (Phase 4)Study completedNCT00324688
What this trial is testing

Safety Study of Once a Day ART and Opiate Substitute.

Who this might be right for
HIV Infections
Gilead Sciences 60
Post-approval studies (Phase 4)Study completedNCT01405027
What this trial is testing

Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy

Who this might be right for
Chronic Hepatitis CGenotype 1
Chronic Liver Disease Foundation 197
Large-scale testing (Phase 3)Study completedNCT01289782
What this trial is testing

An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Patients

Who this might be right for
Hepatitis C
Janssen R&D Ireland 395
Large-scale testing (Phase 3)Ended earlyNCT01051011
What this trial is testing

Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 370
Not applicableUnknownNCT04920500
What this trial is testing

Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients

Who this might be right for
Acute Myeloid Leukemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 16
Large-scale testing (Phase 3)Study completedNCT01497834
What this trial is testing

Study in Combination With BMS-790052 and BMS-650032 in Japanese Hepatitis C Virus (HCV) Patients

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 224
Large-scale testing (Phase 3)Study completedNCT01193244
What this trial is testing

Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 1,560
Testing effectiveness (Phase 2)Study completedNCT00487318
What this trial is testing

Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin

Who this might be right for
Chronic Hepatitis C
Bader, Ted, M.D. 40
Large-scale testing (Phase 3)UnknownNCT00437476
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 60
Post-approval studies (Phase 4)Study completedNCT00299091
What this trial is testing

Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients

Who this might be right for
HIV
Germans Trias i Pujol Hospital 31
Post-approval studies (Phase 4)Study completedNCT00106379
What this trial is testing

Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients

Who this might be right for
HIV Infections
Gilead Sciences 52
Large-scale testing (Phase 3)Study completedNCT00041015
What this trial is testing

Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 4
Early research (Phase 1)Study completedNCT00001968
What this trial is testing

Once-Daily Drug Regimen for HIV-Infected Patients

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Testing effectiveness (Phase 2)Study completedNCT00400738
What this trial is testing

The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 48
Testing effectiveness (Phase 2)Study completedNCT00636740
What this trial is testing

Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients

Who this might be right for
Hormone-Refractory Prostate Cancer
Merrion Pharmaceuticals, LLC 30
Testing effectiveness (Phase 2)Study completedNCT01658878
What this trial is testing

An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Bristol-Myers Squibb 657
Large-scale testing (Phase 3)WithdrawnNCT01797848
What this trial is testing

Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Not applicableStudy completedNCT05520138
What this trial is testing

Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Pfizer 5,506
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation